Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KRP-104 Phase 2 Dose-Finding Study in Type 2 Diabetes Mellitus
jRCT2080220708Phase 2
- Sponsor
- Kyorin Pharmaceutical
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing KRP-104 arm with Placebo arm (2 arms).
02
Drugs
besigliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080220708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220708.